Available Technologies

Subcategories

Results found (15)
No.CategoryTechnology NameBriefcaseLead Researcher
2115
  Category Medical Sciences, Peptide proteinHighlights Increased blood vessel permeability and vascular leak are a final common pathway in severe influenza and other fatal diseases, such as MERS, Ebola and sepsis. A novel biologics therapy ...
More
Ben-Sasson Shmuel
721
Development of a novel cyclic peptide drug to inhibit MyD88 as a key signalling molecule in innate immunity, with application to autoimmune central nervous system disease   Categories Autoimmune disease, Inflammation, Oncology Development ...
More
Nussbaum Gabriel
2622
A specific therapy for treating this serious disease   Categories Mastocytosis, Cancer Development Stage Proof-of-concept, preclinical Patent Status Patent Pending Market Mastocytosis, Mast Cell Leukemia, AllergiesBackground Mast cells ...
More
Levi-Schaffer Francesca
4503
Additional information will be provided upon request
More
Gilon Chaim
574
Additional material on the technology can be supplied upon request
More
Ben-Sasson Shmuel
3111
Additional material on the technology can be supplied upon request
More
Benita Simon
2786
Additional information can be provided upon request
More
Gilon Chaim
3054
  Additional information will be provided upon request
More
Domb Abraham
4273
  Additional information will be provided upon request
More
Shifman Julia
4548
  Additional information will be provided upon request
More
Keshet Eli
3203
Additional information will be provided upon request
More
Nechushtai Rachel
3167
Additional material on the technology can be supplied upon request
More
Ben-Sasson Shmuel
198
  Categories Superactive High Afinity Leptin antagonist, mutein, multiple sclerosis, inflammatory bowel syndrome, rheumatoid arthritis, fibrosis, cardiovascular disease, CKD Cachexia, Osteoarthritis Development Stage (1) In vivo tests in ...
More
Gertler Arieh
2289
Immunomodulatory peptides derived from Japanese rice Categories Peptide, Small Molecule, Inflammatory/Autoimmune diseases Development Stage Proof of concept in MS mouse model Patent Status Patent filed in the United States Market ...
More
Wormser Uri
382
Novel fusion proteins enable ERT for the first time Categories Peptide/Protein, Metabolic, Protein Therapy Development Stage Proof of concept for LAD deficiency and Friedrich Ataxia, in vivo studies in mice Patent Status National ...
More
Galski- Lorberboum Haya